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Feature Articles 
Science or Technology: A Challenge for Clinical Neurosciences 
The clinical neurosciences have experienced dramatic growth during the past ten years. The application of advanced tech-
nology to diagnostic procedures and treatment modalities has 
distinctly altered the practice of physicians concemed with dis-
eases of the nervous system. The dilemma confronting the prac-
titioner is how to reconcile increasing possibilities for interven-
tion in circumstances where the benefit to patients is uncertain. 
This is particularly difficult in an era where technology has cre-
ated its own market among the lay public who unrealistically be-
lieve that medicine is now capable of preserving and restoring 
function in all circumstances. 
The articles in the Journal demonstrate several aspects of this 
issue. Redmond and Ahmad report a case of pontine hemor-
rhage in which the patient had excellent recovery despite early 
signs that indicated likely fatahty. The accompanying editorial 
by Gade provides eloquent expression to the moral and ethical 
dilemmas encountered when technology can preserve life de-
spite serious loss of function. In contrast, two articles concemed 
with interventional radiology indicate the potential for con-
tinued growth of the role that technology may play in preserving 
function. 
Three other articles demonstrate that careful observation and 
attention to clinical detail remain the mainstay of clinical prac-
tice. Teasdall reviews the utility of accurately elicited and appro-
priately analyzed clinical signs in the evaluation of patients with 
neurological deficits. Glasberg et al describe the unexpected 
finding of pathological changes in muscles from patients under-
going total knee replacement, adding another dimension to the 
evaluation of patients with advanced osteoarthritis. Twyman and 
Bivins present a review of the topic of the nutritional require-
ments of patients with severe head injury, including a series of 
clinical investigations carried out over five years. Their data 
challenge accepted clinical practice and lay the groundwork for 
modifications in patient care protocols that could potentially re-
duce morbidity and mortality resulting from severe head injury. 
The discussion of the extracranial-intracranial bypass study 
by Diaz and Ausman addresses a stunning example of the situa-
tion where science and technology diverge. New surgical pro-
cedures utilizing advanced technology uniformly arrive on the 
medical scene to great fanfare. Physicians, generalists and spe-
cialists alike, get caught up in the excitement of discovery and 
the feeling of relief that a new treatment may reduce morbidity 
and mortality in our patients. It is disappointing when a promis-
ing procedure does not live up to its early promise. It is greatly 
disturbing when such procedures enter the mainstream of 
clinical practice before adequate testing of their utility has been 
carried out. 
Within the latter context, the discussion by Diaz and Ausman 
holds much promise. Since the EC-IC bypass study has failed to 
validate the value of this procedure in a carefully controlled 
study, Diaz and Ausman conclude that cerebral revasculariza-
tion procedures are not indicated in daily clinical practice. They 
also call for a randomized controlled study to attempt to find 
a smaller subpopulation that might benefit from a bypass 
procedure. However, only 10% of patients with ischemic cere-
brovascular disease are potential candidates for any surgical pro-
cedure, and of this group only 15% of cases might be identified 
by physiological measures as potential candidates for intra-
cranial bypass. A controlled study to identify surgical candi-
dates from 1% of the stroke population may not be cost-effec-
tive, and it could prove to be difficult to identify sufficient num-
bers of patients to achieve statistical significance. Recognition 
of the need for carefully controlled studies might appropriately 
be extended to all intracranial bypass procedures. The EC-IC 
bypass study tells us that new surgical procedures, in general, 
must undergo the same review as new medications. 
Scientific investigation does not impede the entry of valuable 
treatment modalities into the mainstream of medical practice, 
but science does preserve the credibility of medical practice. 
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